✦ LIBER ✦

Once-weekly teriparatide reduces the risk of vertebral fracture in patients with various fracture risks: subgroup analysis of the Teriparatide Once-Weekly Efficacy Research (TOWER) trial

✍ Scribed by Nakano, Tetsuo; Shiraki, Masataka; Sugimoto, Toshitsugu; Kishimoto, Hideaki; Ito, Masako; Fukunaga, Masao; Hagino, Hiroshi; Sone, Teruki; Kuroda, Tatsuhiko; Nakamura, Toshitaka

Book ID: 121605111
Publisher: Springer
Year: 2013
Tongue: English
Weight: 314 KB
Volume: 32
Category: Article
ISSN: 0914-8779
DOI: 10.1007/s00774-013-0505-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Teriparatide and raloxifene reduce the r

Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials. Bouxsein ML, Chen P, Glass EV, Kallmes DF, Delmas PD, Mitlak BH. J Bone Joint Surg Am. 2009;91(6):1329–38

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 59 KB